BeautyHealth Q4 net loss narrows to $8.1M; adjusted EBITDA margin 18.3%

SkinHealth Systems Inc.

Net sales Q4 $82.4M (down 1% YoY); full year $300.8M (down 10% YoY).
Gross margin improved to 64.4% Q4 and 65.3% FY, up from 62.7% and 54.5%.
Adjusted EBITDA Q4 $15.0M (18.3% margin) vs $9.0M (10.8%) YoY; FY $45.1M vs $12.3M.
Delivery systems sold Q4 1,032 (-5% YoY); active install base rose to 36,026 (+3.7%).
CEO cites operational improvements, strong install base, and recurring consumables model.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SkinHealth Systems Inc. reported financial results for fiscal quarter and year ended December 31, 2025.

Period: fiscal quarter and year ended December 31, 2025
Result: reported results

Exact text from the filing

On March 12, 2026, The Beauty Health Company (the “Company”) issued a press release and will hold a conference call regarding its financial results for its fiscal quarter and year ended December 31, 2025.

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-017222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.